In vitro diagnostics (IVD) are central to modern healthcare, enabling accurate disease detection, monitoring, and personalized treatment decisions. Companies in this segment face rapid technological advancement, including molecular diagnostics, point-of-care testing, and high-throughput laboratory systems. Adoption depends on clinical accuracy, regulatory approval, integration with laboratory workflows, and alignment with payer reimbursement frameworks. Regulatory landscapes are complex, with regional variations in approval pathways, quality standards, and post-market surveillance requirements. Geopolitical factors such as trade policies, tariffs, and international data-sharing regulations can affect market entry and global commercialization. Hospitals and laboratories demand instruments and consumables that are reliable, scalable, and cost-effective, with a strong emphasis on automation, interoperability, and digital integration. Companies must balance innovation with operational efficiency and portfolio management to remain competitive in a fast-evolving environment.

We support IVD companies across the full spectrum of strategic and operational capabilities. 

  • Corporate Strategy: we define global ambitions, prioritize diagnostic portfolios, assess market opportunities, design business models, and develop multi-year growth plans, including market entry, partnerships, and alliances
  • Customer Insights: we map stakeholders – including laboratory directors, clinicians, and payers – capture the voice of users, and refine value propositions to optimize adoption and impact
  • Commercial Strategy: we develop go-to-market models, launch readiness programs, commercial excellence initiatives, competitive benchmarking, and strategic differentiation
  • Medical Affairs: we support evidence generation, clinical validation, and engagement with laboratory and clinical professionals to reinforce scientific credibility
  • Market Access: we advise on global access strategies, pricing and reimbursement assessments and value-based healthcare approaches tailored to diagnostic adoption
  • R&D and Innovation: we optimize innovation sourcing, portfolio prioritization, lifecycle management, and R&D processes to accelerate high-value diagnostic development
  • M&A and Transactions: we conduct commercial and vendor due diligence, build-up strategies, acquisition planning, and post-merger integration

By combining deep sector expertise with end-to-end strategic and operational support, we help IVD companies accelerate growth, optimize portfolios, navigate regulatory and geopolitical complexity, strengthen adoption, and deliver meaningful patient and healthcare system impact worldwide.